Hemorrhagic and thrombotic events associated with generic substitution of warfarin in patients with atrial fibrillation: a retrospective analysis.

PubWeight™: 1.61‹?› | Rank: Top 4%

🔗 View Article (PMID 21666081)

Published in Ann Pharmacother on June 10, 2011

Authors

Sameer R Ghate1, Joseph E Biskupiak, Xiangyang Ye, Michael Hagan, Winghan Jacqueline Kwong, Eben S Fox, Diana I Brixner

Author Affiliations

1: Department of Pharmacotherapy, University of Utah, Salt Lake City, UT, USA.

Articles by these authors

All-cause and incremental per patient per year cost associated with chronic hepatitis C virus and associated liver complications in the United States: a managed care perspective. J Manag Care Pharm (2011) 1.44

Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids. Int J Chron Obstruct Pulmon Dis (2012) 1.37

Results of a retrospective, observational pilot study using electronic medical records to assess the prevalence and characteristics of patients with resistant hypertension in an ambulatory care setting. Clin Ther (2009) 1.18

All-cause and bleeding-related health care costs in warfarin-treated patients with atrial fibrillation. J Manag Care Pharm (2011) 1.15

Effect of Medicare reimbursement reduction for imaging services on osteoporosis screening rates. J Am Geriatr Soc (2012) 1.14

Importance of side effects in opioid treatment: a trade-off analysis with patients and physicians. J Pain (2010) 1.13

Evaluating Diagnosis and Treatment Patterns of COPD in Primary Care. Treat Respir Med (2006) 1.13

Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based chemotherapy: a report from the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys (2005) 1.11

An examination of the electrostatic interactions between the N-terminal tail of the Brome Mosaic Virus coat protein and encapsidated RNAs. J Mol Biol (2012) 1.04

The costs of warfarin underuse and nonadherence in patients with atrial fibrillation: a commercial insurer perspective. J Manag Care Pharm (2013) 1.03

The economic impact of GERD and PUD: examination of direct and indirect costs using a large integrated employer claims database. Curr Med Res Opin (2005) 1.03

Antiplatelet medication management in patients hospitalized with ischemic stroke. Am J Health Syst Pharm (2007) 1.03

Clinical risk factors for fracture in postmenopausal osteoporotic women: a review of the recent literature. Ann Pharmacother (2008) 1.01

Application of electronic medical record data for health outcomes research: a review of recent literature. Expert Rev Pharmacoecon Outcomes Res (2013) 1.01

Burden of premenstrual dysphoric disorder on health-related quality of life. J Womens Health (Larchmt) (2008) 1.00

Impact of metformin-induced gastrointestinal symptoms on quality of life and adherence in patients with type 2 diabetes. Postgrad Med (2010) 0.99

Anticoagulation therapy for patients with non-valvular atrial fibrillation: comparison of decision analytic model recommendations and real-world warfarin prescription use. Am J Cardiovasc Drugs (2012) 0.92

Development of a practical screening tool to predict low muscle mass using NHANES 1999-2004. J Cachexia Sarcopenia Muscle (2013) 0.90

Development and validation of the Premenstrual Symptoms Impact Survey (PMSIS): a disease-specific quality of life assessment tool. J Womens Health (Larchmt) (2008) 0.89

Assessing adherence-based quality measures in epilepsy. Int J Qual Health Care (2012) 0.89

Adherence and persistence with single-dosage form extended-release niacin/lovastatin compared with statins alone or in combination with extended-release niacin. Ann Pharmacother (2006) 0.89

Adherence with multiple-combination antihypertensive pharmacotherapies in a US managed care database. Clin Ther (2008) 0.89

Characteristics affecting oral anticoagulant therapy choice among patients with non-valvular atrial fibrillation: a retrospective claims analysis. BMC Health Serv Res (2014) 0.87

Comparison of daily insulin dose and other antidiabetic medications usage for type 2 diabetes patients treated with an analog basal insulin. Curr Med Res Opin (2010) 0.87

Burden of opioid-associated gastrointestinal side effects from clinical and economic perspectives: a systematic literature review. J Opioid Manag (2010) 0.86

Fat Modulates the Relationship between Sarcopenia and Physical Function in Nonobese Older Adults. Curr Gerontol Geriatr Res (2012) 0.86

Incidence and economic implications of heparin-induced thrombocytopenia in medical patients receiving prophylaxis for venous thromboembolism. Pharmacotherapy (2006) 0.85

Impact of adherence and weight loss on glycemic control in patients with type 2 diabetes: cohort analyses of integrated medical record, pharmacy claims, and patient-reported data. J Manag Care Spec Pharm (2014) 0.85

Gastrointestinal complications of over-the-counter nonsteroidal antiinflammatory drugs. J Pain Palliat Care Pharmacother (2006) 0.85

New therapies for treating Down syndrome require quality of life measurement. Am J Med Genet A (2013) 0.84

Advances in contraception: IUDs from a managed care perspective. J Womens Health (Larchmt) (2008) 0.82

Organ quality and quality of life after liver transplantation. Liver Transpl (2011) 0.82

Clinical risk factors for fracture among postmenopausal patients at risk for fracture: a historical cohort study using electronic medical record data. J Bone Miner Metab (2010) 0.80

Physician adherence to ACR gout treatment guidelines: perception versus practice. Postgrad Med (2014) 0.79

Use of clomiphene citrate in the University of Utah Community Clinics. J Reprod Med (2013) 0.78

Concurrent control of blood glucose, body mass, and blood pressure in patients with type 2 diabetes: an analysis of data from electronic medical records. Clin Ther (2011) 0.78

Clinical, humanistic, and economic outcomes of gout. Am J Manag Care (2005) 0.78

Has the cost-effectiveness of Xolair (omalizumab) been underestimated? J Allergy Clin Immunol (2005) 0.78

Trends and predictors in methadone maintenance treatment dropout in Shanghai, China: 2005-2011. Curr Med Res Opin (2013) 0.78

Cost effectiveness of pharmacotherapy for the prevention of migraine: a Markov model application. CNS Drugs (2010) 0.78

Predictors of metabolic parameter monitoring in adolescents on antipsychotics in a primary care setting. Ment Health Fam Med (2012) 0.77

Metabolic monitoring of patients prescribed second-generation antipsychotics. J Psychiatr Pract (2013) 0.77

Assessment of time to follow-up visits in newly-treated hypertensive patients using an electronic medical record database. Curr Med Res Opin (2010) 0.77

A review of recommended antibiotic therapies with impact on outcomes in acute otitis media and acute bacterial sinusitis. Am J Manag Care (2006) 0.77

Impact of body mass index on the incidence of cardiometabolic risk factors in ambulatory care settings over 5 years or more. Value Health (2009) 0.77

Characterization of patients undergoing total hip arthroplasty in a real-world setting and pain-related medication prescriptions for management of postoperative pain. J Pain Palliat Care Pharmacother (2013) 0.77

Characterization of clinical course and usual care patterns in female metastatic breast cancer patients treated with zoledronic acid. Breast (2012) 0.77

Review of economics and cost-effectiveness analyses of anticoagulant therapy for stroke prevention in atrial fibrillation in the US. Ann Pharmacother (2013) 0.76

Characterization of patients undergoing total knee arthroplasty in a real-world setting and pain-related medication prescriptions for management of postoperative pain. J Pain Palliat Care Pharmacother (2012) 0.76

Application of decision-analytic models in personalized medicine for CML treatment decisions made by payers, providers, and patients. J Manag Care Pharm (2012) 0.76

Airway pressure release ventilation and successful lung donation. Arch Surg (2011) 0.76

Definition of medical event is to be based on the total source strength for evaluation of permanent prostate brachytherapy: A report from the American Society for Radiation Oncology. Pract Radiat Oncol (2011) 0.75

Investigations of interference between electromagnetic transponders and wireless MOSFET dosimeters: a phantom study. Med Phys (2011) 0.75

Contemporary management of patients with Type 2 diabetes. Expert Rev Cardiovasc Ther (2010) 0.75

Management of epilepsy in adults. Treatment guidelines. Postgrad Med (2005) 0.75

Quality initiatives in transplantation. Prog Transplant (2009) 0.75

Physician utilization by insurance type among youth with type 2 diabetes. Am J Manag Care (2010) 0.75

Evaluating the impact of partnerships to improve clinical quality. Jt Comm J Qual Patient Saf (2007) 0.75

Estimating the dose response relationship for occupational radiation exposure measured with minimum detection level. Health Phys (2004) 0.75

Contraceptive and noncontraceptive benefits of the LNG-IUS in a vertically integrated HMO. Contraception (2008) 0.75

Association between second-generation antipsychotics and changes in body mass index in adolescents. J Adolesc Health (2013) 0.75

Back pain and productivity: measuring worker productivity from an employer's perspective. J Pain Palliat Care Pharmacother (2004) 0.75

Review of challenges in optimizing oral anticoagulation therapy for stroke prevention in atrial fibrillation. Am J Cardiovasc Drugs (2013) 0.75

Rethinking the total cost of care in AOM and ABS: The impact of improved diagnostic accuracy and antibiotic treatment where high efficacy and adherence are achievable. Am J Manag Care (2006) 0.75

Research to real-world application: experts weigh in on the underuse of anticoagulants. Am J Manag Care (2014) 0.75

Management of epilepsy in adults. Diagnosis guidelines. Postgrad Med (2005) 0.75

Introduction and commentary for special issue simulation techniques in health services research. Health Serv Res (2013) 0.75